» Articles » PMID: 35762310

LncRNA DHFRL1‑4 Knockdown Attenuates Cerebral Ischemia/reperfusion Injury by Upregulating the Levels of Angiogenesis‑related Genes

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2022 Jun 28
PMID 35762310
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aimed to investigate the effects of long non‑coding (lncRNA) dihydrofolate reductase‑like 1 (DHFRL1‑4) on cerebral ischemia/reperfusion (I/R)‑induced injury. For this purpose, mice injected with lentivirus with small interfering RNA targeting DHFRL1‑4 or negative control siRNA were used to construct models of cerebral I/R injury. Following the establishment of the model, the infarct size, neurological deficit score, apoptosis and the expression levels of basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), Wnt family member 3a (Wnt3a), glycogen synthase kinase‑3β (GSK‑3β) and phosphorylated GSK‑3β were assessed. The expression of DHFRL1‑4 was significantly upregulated in the I/R model. In the control and sham groups, the boundaries between the cortex and gray matter were clear, and no edema or necrosis were observed. The nerve cells were arranged orderly and evenly, and the cell membranes were intact with visible nucleus and nucleolus. In the model group however, the nerve fibers were slightly necrotic and swollen, and the number of nerve cells was reduced. In the mice injected with si‑DHFRL1‑4 lentivirus, the brain tissues exhibited less liquefaction and degeneration, as well as less edema. Compared with the control and sham groups, the model group had a significantly larger infarct area, a higher apoptotic rate, higher bFGF, VEGF, Wnt3a and GSK‑3β expression levels and a greater neurological deficit score. However, the mice injected with si‑DHFRL1‑4 lentivirus exhibited a significantly reduced infarct area, a lower apoptotic rate, lower Wnt3a and GSK‑3β expression levels, a lower neurological deficit score, and significantly upregulated bFGF and VEGF levels.

Citing Articles

M6A Modification and Transcription Analysis of LncRNA in Cerebral Ischemia/Reperfusion Injury.

Mo J, Li Z, Yang Z, Huang Z, Guo P, Gao J Int J Genomics. 2024; 2024:4596974.

PMID: 39397896 PMC: 11470819. DOI: 10.1155/2024/4596974.


Angiogenesis after ischemic stroke.

Fang J, Wang Z, Miao C Acta Pharmacol Sin. 2023; 44(7):1305-1321.

PMID: 36829053 PMC: 10310733. DOI: 10.1038/s41401-023-01061-2.

References
1.
Prabhakaran S, Ruff I, Bernstein R . Acute stroke intervention: a systematic review. JAMA. 2015; 313(14):1451-62. DOI: 10.1001/jama.2015.3058. View

2.
Lu Y, Han Y, He J, Zhou B, Fang P, Li X . LncRNA FOXD3-AS1 knockdown protects against cerebral ischemia/reperfusion injury via miR-765/BCL2L13 axis. Biomed Pharmacother. 2020; 132:110778. DOI: 10.1016/j.biopha.2020.110778. View

3.
Fischer A, Jacobson K, Rose J, Zeller R . Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc. 2011; 2008:pdb.prot4986. DOI: 10.1101/pdb.prot4986. View

4.
Kubo H, Hayashi T, Ago K, Ago M, Kanekura T, Ogata M . Temporal expression of wound healing-related genes in skin burn injury. Leg Med (Tokyo). 2013; 16(1):8-13. DOI: 10.1016/j.legalmed.2013.10.002. View

5.
Kilkenny C, Browne W, Cuthill I, Emerson M, Altman D . Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010; 8(6):e1000412. PMC: 2893951. DOI: 10.1371/journal.pbio.1000412. View